Breaking News Instant updates and real-time market news.

TW

Tradeweb Markets

$41.50

-1.7 (-3.94%)

05:49
10/21/19
10/21
05:49
10/21/19
05:49

Tradeweb Markets upgraded to Buy from Neutral at UBS

UBS analyst Alex Kramm upgraded Tradeweb Markets to Buy from Neutral with a price target of $49, up from $47. With the overhang of the secondary now removed, the stock's valuation is "much more attractive," Kramm tells investors in a research note. The analyst, who notes the shares are down 17% since the July peak, believes Tradeweb will move back toward its recent highs. Kramm sees potential for upside from acceleration in the electronification of fixed income markets and higher levels of volatility.

  • 07

    Nov

TW Tradeweb Markets
$41.50

-1.7 (-3.94%)

10/01/19
10/01/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ericsson (ERIC) upgraded to Buy from Hold at Canaccord with analyst Michael Walkley saying since the Q2 earnings report, Ericsson has announced deals with Nex-Tech, RINA, and KDDI, demonstrating continuing 5G momentum. 2. VMware (VMW) upgraded to Outperform from Market Perform at Wells Fargo with analyst Philip Winslow saying investors have been concerned that growing interest in deploying containerized applications into Kubernetes-centric environments will eventually reduce customer demand for VMware's virtualization-centric product portfolio. 3. Tradeweb Markets (TW) upgraded to Overweight from Equal Weight at Barclays with analyst Jeremy Campbell saying recent weakness in the shares "seems largely technical," which presents an "attractive upside opportunity." 4. Scotts Miracle-Gro (SMG) upgraded to Neutral from Underperform at BofA/Merrill with analyst Christopher Carey saying the bar on the company's earnings consensus may be "too low." 5. Philip Morris (PM) upgraded to Buy from Neutral at BofA/Merrill with analyst Lisa Lewandowski citing the suspended merger discussions with Altria (MO) amid the heightened risk for U.S. vaping category following reports of lung health concerns. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/01/19
LEHM
10/01/19
UPGRADE
Target $45
LEHM
Overweight
Barclays upgrades Tradeweb Markets to Overweight after pullback
Barclays analyst Jeremy Campbell upgraded Tradeweb Markets to Overweight from Equal Weight with an unchanged price target of $45. Recent weakness in the shares "seems largely technical," which presents an "attractive upside opportunity," Campbell tells investors in a research note. The analyst sees $34 per share as near-term valuation support with upside back to the low-to-mid $40's. Further, with exchange sentiment high and structural growth stories in demand, the market to absorb any forthcoming supply from the lock-up expiration, and Tradeweb has balance sheet flexibility to "buy-back some unlocked stock," says Campbell.
10/01/19
LEHM
10/01/19
UPGRADE
Target $45
LEHM
Overweight
Tradeweb Markets upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Jeremy Campbell upgraded Tradeweb Markets to Overweight from Equal Weight with a price target of $45.
09/13/19
BOFA
09/13/19
UPGRADE
BOFA
Buy
Tradeweb Markets upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Michael Carrier upgraded Tradeweb Markets to Buy from Neutral with the stock down 16% since the end of July. Meanwhile, the company's volumes continue to outperform expectations and management as shown the ability to drive revenues and margin gains relative to peers, Carrier tells investors in a research note.

TODAY'S FREE FLY STORIES

CELG

Celgene

$110.03

-0.42 (-0.38%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Hot Stocks
Celgene receives positive CHMP opinion for REVLIMID »

Celgene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Hot Stocks
J.C. Penney CEO says 'made significant progress' on efforts to return to growth »

"The past quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BABA

Alibaba

$182.69

0.21 (0.12%)

, STAY

Extended Stay America

$14.69

0.12 (0.82%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BABA

Alibaba

$182.69

0.21 (0.12%)

STAY

Extended Stay America

$14.69

0.12 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMAT

Applied Materials

$56.89

-0.24 (-0.42%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Recommendations
Applied Materials analyst commentary  »

Applied Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:33
11/15/19
11/15
07:33
11/15/19
07:33
Hot Stocks
J.C. Penney expects FY19 adjusted EBITDA to exceed $475M »

In addition, the Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

RIGL

Rigel Pharmaceuticals

$2.29

-0.065 (-2.77%)

07:32
11/15/19
11/15
07:32
11/15/19
07:32
Hot Stocks
Rigel Pharmaceuticals receives positive CHMP opinion for fostamatinib »

Rigel Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:32
11/15/19
11/15
07:32
11/15/19
07:32
Hot Stocks
J.C. Penney reports Q3 SSS down 9.3% »

Adjusted comparable store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CGC

Canopy Growth

$15.84

-2.68 (-14.47%)

07:32
11/15/19
11/15
07:32
11/15/19
07:32
Recommendations
Canopy Growth analyst commentary  »

Canopy Growth price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Earnings
J.C. Penney reports Q3 adjusted EPS (30c), consensus (55c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ADS

Alliance Data

$106.55

-0.57 (-0.53%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Hot Stocks
Alliance Data reports October net charge offs 6.6% vs. 5.3% last month »

Reports October…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$56.89

-0.24 (-0.42%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Recommendations
Applied Materials analyst commentary  »

Applied Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

TORC

resTORbio

$7.93

-0.47 (-5.60%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Hot Stocks
Breaking Hot Stocks news story on resTORbio 

resTORbio trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTCH

Farfetch

$7.49

-0.54 (-6.72%)

07:30
11/15/19
11/15
07:30
11/15/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$120.65

-0.41 (-0.34%)

07:28
11/15/19
11/15
07:28
11/15/19
07:28
Recommendations
Walmart analyst commentary  »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTCH

Farfetch

$7.49

-0.54 (-6.72%)

07:26
11/15/19
11/15
07:26
11/15/19
07:26
Recommendations
Farfetch analyst commentary  »

Farfetch price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$21.49

(0.00%)

07:25
11/15/19
11/15
07:25
11/15/19
07:25
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin shares up 21c to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

GLPG

Galapagos

$183.48

-7.74 (-4.05%)

, GILD

Gilead

$63.79

0.46 (0.73%)

07:25
11/15/19
11/15
07:25
11/15/19
07:25
Recommendations
Galapagos, Gilead analyst commentary  »

Galapagos price target…

GLPG

Galapagos

$183.48

-7.74 (-4.05%)

GILD

Gilead

$63.79

0.46 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 21

    Feb

VAR

Varian Medical

$125.01

0.45 (0.36%)

07:25
11/15/19
11/15
07:25
11/15/19
07:25
Conference/Events
Varian Medical to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

OCUL

Ocular Therapeutix

$2.67

-0.1 (-3.61%)

07:23
11/15/19
11/15
07:23
11/15/19
07:23
Recommendations
Ocular Therapeutix analyst commentary  »

Ocular Therapeutix price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$26.68

-1.42 (-5.05%)

07:23
11/15/19
11/15
07:23
11/15/19
07:23
Downgrade
CenterPoint Energy rating change  »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBLX

Noble Midstream

$22.29

-0.36 (-1.59%)

07:22
11/15/19
11/15
07:22
11/15/19
07:22
Recommendations
Noble Midstream analyst commentary  »

Noble Midstream price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$21.43

-0.08 (-0.37%)

07:22
11/15/19
11/15
07:22
11/15/19
07:22
Conference/Events
Associated Banc-Corpmanagement to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 18

    Nov

NVDA

Nvidia

$209.88

1.33 (0.64%)

07:21
11/15/19
11/15
07:21
11/15/19
07:21
Upgrade
Nvidia rating change  »

Nvidia upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 06

    Jan

NCNA

NuCana

$5.59

-0.35 (-5.89%)

07:21
11/15/19
11/15
07:21
11/15/19
07:21
Recommendations
NuCana analyst commentary  »

NuCana price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$21.49

(0.00%)

07:19
11/15/19
11/15
07:19
11/15/19
07:19
Recommendations
Amarin shares could move towards $51 after positive vote, says H.C. Wainwright »

Following the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.